Corcept Therapeutics Incorporated (NASDAQ:CORT) ranks among the most profitable biotech stocks to buy now. At the Society of ...
Cort has turned its knack for quality yet affordable guitar builds to the acoustic guitar world once more, and believes its new Essence series delivers “quintessential classic acoustic guitars”. Two ...
Zacks Investment Research on MSN
CORT Q1 earnings match estimates, revenues miss, 2026 outlook raised
Corcept Therapeutics CORT incurred a first-quarter 2026 loss of 30 cents per share, in line with the Zacks Consensus Estimate ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Cort Cort has added ...
On April 11, Corcept Therapeutics Inc. (NASDAQ:CORT) released the overall survival results from its Phase 3 ROSELLA study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results